The current status of acellular pertussis vaccines

References

1. Brown F., Greco D., Mastrantonio P., Salmaro S., Wassilak S. Pertussis Vaccines Trials, Rome. 30 Oct.-l Nov. 1995: Trial synopses Rome: Istituto Superiore di Sanita, 1995. Dev Biol Stand 1997; 89: (in press)
   [Google Scholar]
2. Pertussis Conference National Institutes of Health, Acellular Pertussis Vaccine Trials: results and impact on U. S. Public Health. 3–5 June 1996 National Institutes of Health; Washington, DC, USA:
   [Google Scholar]
3. WHO/IABS/NIBSC International Meeting on the Control and Standardisation of Acellular Pertussis Vaccines. 26–27 Sept Potters Bar; UK: Dev Biol Stand 1997; 89 (in press)
   [Google Scholar]
4. Ibsen P. H. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. Vaccine 1996; 14:359–368
   [Google Scholar]
5. Poland G. A. Acellular pertussis vaccines: new vaccines for an old disease. Lancet 1996; 347:209–210
   [Google Scholar]
6. Schmitt H. J. Results of a household contact protective efficacy study. Presented at: Caring for the new generation. Conference; Sorrento; Italy:6–7 April 1995 Abstract (p. 37)
   [Google Scholar]
7. Edwards K. M., Meade B. D., Decker M. D. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995; 96:548–557
   [Google Scholar]
8. Zepp F., Knuf M., Habermehl P. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 1996; 64:4078–4084
   [Google Scholar]
9. Barnard A., Mahon B. P., Watkins J., Redhead K., Mills K. H. G. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 1996; 87:372–380
   [Google Scholar]
10. Gustafsson L., Hallander H. O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334:349–355
    [Google Scholar]
11. Greco D., Salmaso S., Mastrantonio P. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334:341–348
    [Google Scholar]
12. Olin P., Gustafson L., Rasmussen F., Hallonder H., Heijbel H., Gottfarb P. Efficacy trial of acellular pertussis vaccines. Technical Report II; 1997 Stockholm: Swedish Institute for Infectious Disease Control;
    [Google Scholar]
13. Sato Y., Sato H. Animal models in pertussis. In Wardlaw A. C., Parton R. (eds) Pathogenesis and immunity in pertussis Chichester: John Wiley and Sons; 1988309–325
    [Google Scholar]